Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults Shingrix is a non-live safe vaccine that is very effective in preventing shingles, the potentially devastating painful reoccurrence of the... August 1, 2021TreatmentBy Brad Hedrick
EHA 2019: Dr. Susan O’Brien on Frontline Therapy in CLL Dr. Susan O’Brien moved from MD Anderson to head up the CLL research and clinical team at the University of... November 18, 20192019 Conferences, TreatmentBy Brad Hedrick
Vaccines for CLL Patients The US CDC ACIP (Center for Disease Control - Advisory Committee on Immunization Practices) provides specific vaccine recommendations for people with... October 21, 2019TreatmentBy Brad Hedrick
Things to Know About Idelalisib By Tom Henry – CLL Patient and Pharmacist Idelalisib (eye-del-a-lis-ib), which is marketed under the tradename of Zydelig® in the United... March 28, 2018TreatmentBy clladm1n
New Formulation of Imbruvica (ibrutinib) – Commentary Dr. Furman has been involved in the development of ibrutinib since its very earliest trials. This discussion was triggered by the... March 27, 2018TreatmentBy Todd Dennison
Things to Know About Venetoclax (updated 5/4/2020) When most of us think of a pharmacist we think of them primarily in the role of retail pharmacy, the... December 28, 2017TreatmentBy clladm1n
One Man’s Opinion: Dr. Rick Furman on the Diminished Role of FCR in treating CLL Dr. Rick Furman of Weill-Cornell answers your questions in our ASK THE DOCTOR feature in our quarterly newsletters, responds to... December 5, 2017TreatmentBy Todd Dennison
Things to Know About Ibrutinib By Tom Henry – CLL Patient and Pharmacist Ibrutinib (eye-broo-ti-nib), which is marketed under the tradename of Imbruvica® in the... September 27, 2017TreatmentBy clladm1n
The Role of the Pharmacist in CLL When most of us think of a pharmacist we think of them primarily in the role of retail pharmacy, the... June 27, 2017The Basics, TreatmentBy Brian Koffman
Steroids: Short-Term Use and the Increased Risk of Serious Complications: Correlation versus Causation (Part 3) Introduction This is the last of a three-part series on the risks and benefits of steroids in CLL. This section reviews a... May 9, 2017TreatmentBy Todd Dennison
